You searched for "Glaucoma UK"
Local campaigner with glaucoma from Manchester shortlisted for RNIB See Differently Award
A man from Manchester has been shortlisted for an RNIB See Differently Award in recognition of his campaigning to raise awareness of glaucoma and the importance of eye care among young people and those of East Asian heritage.The future of glaucoma management: From sustained drug delivery to remote IOP monitoring
Glaucoma is a leading cause of irreversible vision loss worldwide, affecting millions around the globe [1]. Despite major advances in glaucoma treatment, complications of surgery and long-term disease management remain challenging due to poor adherence to topical medications, fluctuating intraocular...
Atlas Optical Coherence Tomography of Macular Diseases and Glaucoma
The book is divided into three sections: an introduction to optical coherence tomography (OCT), the OCT in macular diseases, and glaucoma. The first section lists the currently commercially available OCT machines, then describes the techniques for acquiring OCT images using...
Glaucoma medications and ocular surface disease
This literature review examined ocular surface disease (OSD) associated with glaucoma medication. The authors examined the prevalence of features and management guidelines glaucoma medication associated OSD. Fifty-eight articles published within the past five years are included in this review and...Moorfields Education: Glaucoma level 3 (College of Optometrists Professional Diploma in Glaucoma) 2025
This course is designed to build up from levels 1 and 2 to further develop skills in detecting change in clinical status and decision-making in patients with established glaucoma of all types in adult patients. Entry requirementsPossess a minimum of...‘Phaco-plus’ procedures at forefront of modern glaucoma management
Glaucoma and cataract increasingly present as a ‘two-in-one’ surgical opportunity. In the UK, new modelling suggests ~1 million adults aged ≥40 may currently have glaucoma, with a projected rise to ~1.6 million by 2060 as the population ages and demographics...End stage glaucoma management
A 48-year-old female has had multiple drug treatment for glaucoma and is still losing field of vision. How do you manage this over time? This patient is at high-risk for going blind and should be managed aggressively to protect remaining...Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.New GIRFT glaucoma guidance – opportunities for improvement through primary eyecare services
Primary eyecare organisations have welcomed the publication of NHS England's Getting It Right First Time (GIRFT) Best Practice Guidance for Glaucoma Services. If implemented by ICBs as intended, the new guidance should mark an important step forward in the delivery...The benefits of hospital-based training: Bridging the gap in skills acquisition
Developing countries have a significant burden of eye disease that is compounded by severe shortages of specialised skills, presenting a critical global ophthalmology challenge. Many ophthalmologists may seek to pursue specialised training upon completion of their postgraduate studies. Much of...
Protecting retinal ganglion cells
Glaucoma is considered to be a heterogeneous group of conditions giving retinal ganglion cells (RGC) damage. Lowering intraocular pressure (IOP) reduces the risk of progressive RGC loss in glaucoma. Regeneration of the optic nerve has been shown to restore some...
